Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Wednesday, June 20, 2018 · 452,360,263 Articles · 3+ Million Readers

Global Respiratory Drugs and Devices Market Research and Forecast, 2018-2023

Orion Market Research Pvt. Ltd.

Industry Market Research Report and Consulting

Global Respiratory Drugs and Devices Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

High prevalence of the chronic respiratory disease such as asthma is the major driver for the growth of respiratory drugs and devices market.”
— OMR Analyst

INDORE, INDIA, March 14, 2018 /EINPresswire.com/ -- Orion Market Research (OMR), recently published a market research report on the Global respiratory drugs and devices market. According to the OMR analysis, the Global respiratory drugs and devices market is expected to grow at a CAGR of 7% during 2018-2023. The global respiratory drugs and devices market has witnessed a significant growth due to increasing prevalence of chronic respiratory diseases across the globe. The global respiratory drugs and devices market is segmented on the basis products, respiratory drugs, end users, and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, sector analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

The full report of Global Respiratory Drugs and Devices Market is available at https://www.omrglobal.com/industry-reports/respiratory-drugs-devices-market/

“The Global Respiratory Drugs and Devices Market has been motivated by the increasing prevalence of chronic respiratory diseases globally. Asthma is a chronic lung disease that narrows the airways. Both children and adults are affected by asthma. It is estimated that 300 million people of all ages are affected by asthma and 250,000 die due to asthma. Another major respiratory problem is the chronic obstructive pulmonary diseases (COPD). It is the 4th leading cause of death in US. Approximately, 142,000 people died of COPD in 2014 and almost the same number of people died of lung cancer in the same year. This increasing prevalence of chronic respiratory disease has resulted in higher diagnosis rate and prescription of respiratory drugs.”

The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow at a stable CAGR. North American market is driven by high sales of branded drugs and a high number of patient diagnosed and treated for respiratory diseases. North American marker is followed by Europe, Asia Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR amongst all regions for the forecasted period of 2018-2023. APAC market is driven by growing aging population with respiratory disorders. Furthermore, pollution and lifestyle changes are driving the APAC market.

The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, patent analysis, pipeline analysis, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.”

Companies Profiled:
1. AstraZeneca
2. Adamis (ADMP)
3. ADS Biotechnology
4. Air Liquide
5. Alios BioPharma Inc.
6. ALung Technologies
7. Alvogen
8. Anaxsys
9. Applied Biocode Inc
10. Aptimmune Biologics Inc
11. Aptuit
12. Aradigm
13. Aros Pharma ApS
14. Arrow Therapeutics, Ltd.
15. Avita Medical
16. Baxter International
17. Bayer AG
18. Beximco Pharmaceuticals Ltd
19. BioMarck Pharmaceuticals, Ltd
20. Bioxydyn Limited
21. Boehringer Ingelheim
22. Capellon Pharmaceuticals, Ltd.
23. Chart Industries
24. Chiesi Farmaceutici S.p.A
25. Circadiance
26. Circassia.
27. Civitas Therapeutics, Inc.
28. Compumedics limited
29. Covidien plc
30. Dainippon Sumitomo Pharma Co., Ltd.
and 73 more leading companies.

For related reports please visit http://www.omrglobal.com/reports-category/medical-devices/
The report covers:
• Comprehensive research methodology of respiratory drugs and devices market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global drugs and devices market
• Insights about market determinants which are stimulating the global respiratory drugs and devices market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company Profiling, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provides a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Powered by EIN Presswire